10-K/A

BIOTIME 10-K A 12-31-2011

Company: Lineage Cell Therapeutics, Inc.
Filed: September 17, 2012
Period of Report: December 31, 2011
Accession Number: 0001140361-12-040671

View Document ↗ View on SEC.gov ↗